PAK1IP1 is a nucleolar protein that functions as a negative regulator of PAK1 kinase signaling. PAK1IP1 binds to the N-terminus of PAK1 and inhibits its activation by CDC42 1, thereby suppressing downstream PAK1/ERK1/2 signaling cascades. The protein plays a crucial role in ribosomal biogenesis and rRNA processing 2, and responds to ribosomal stress by regulating the p53-MDM2 feedback loop 2. PAK1IP1 inhibits MDM2-mediated p53 ubiquitination, leading to p53 accumulation and G1 cell-cycle arrest 2. Clinically, PAK1IP1 dysfunction is associated with craniofacial abnormalities. Mouse Pak1ip1 mutations cause severe orofacial clefting through loss of neural crest cells and impaired cell cycle progression 34, with human PAK1IP1 mapping to chromosome 6 translocation breakpoints in orofacial clefting cases 3. In hepatocellular carcinoma, PAK1IP1 is upregulated and promotes tumor progression; knockdown suppresses HCC proliferation and migration while inducing pyroptosis 5. PAK1IP1 also influences cardiovascular pathology, where TBK1-mediated PAK1IP1 inhibition promotes endothelial-to-mesenchymal transition and atherogenesis 1. These findings position PAK1IP1 as a multifunctional regulator with implications for developmental, oncologic, and cardiovascular diseases.